» Articles » PMID: 32164319

The Susceptibility of Retinal Ganglion Cells to Optic Nerve Injury is Type Specific

Overview
Journal Cells
Publisher MDPI
Date 2020 Mar 14
PMID 32164319
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Retinal ganglion cell (RGC) death occurs in many eye diseases, such as glaucoma and traumatic optic neuropathy (TON). Increasing evidence suggests that the susceptibility of RGCs varies to different diseases in an RGC type-dependent manner. We previously showed that the susceptibility of several genetically identified RGC types to -methyl-D-aspartate (NMDA) excitotoxicity differs significantly. In this study, we characterize the susceptibility of the same RGC types to optic nerve crush (ONC). We show that the susceptibility of these RGC types to ONC varies significantly, in which BD-RGCs are the most resistant RGC type while W3-RGCs are the most sensitive cells to ONC. We also show that the survival rates of BD-RGCs and J-RGCs after ONC are significantly higher than their survival rates after NMDA excitotoxicity. These results are consistent with the conclusion that the susceptibility of RGCs to ONC varies in an RGC type-dependent manner. Further, the susceptibilities of the same types of RGCs to ONC and NMDA excitotoxicity are significantly different. These are valuable insights for understanding of the selective susceptibility of RGCs to various pathological insults and the development of a strategy to protect RGCs from death in disease conditions.

Citing Articles

Immunomodulation by the combination of statin and matrix-bound nanovesicle enhances optic nerve regeneration.

Campbell G, Amin D, Hsieh K, Hussey G, St Leger A, Gross J NPJ Regen Med. 2024; 9(1):31.

PMID: 39461953 PMC: 11513974. DOI: 10.1038/s41536-024-00374-y.


Concept of Normativity in Multi-Omics Analysis of Axon Regeneration.

Moceri I, Meehan S, Gonzalez E, Park K, Hackam A, Lee R Biomolecules. 2024; 14(7).

PMID: 39062450 PMC: 11274927. DOI: 10.3390/biom14070735.


Circular RNA-based therapy provides sustained and robust neuroprotection for retinal ganglion cells.

Jiang W, Xiao D, Wu C, Yang J, Peng X, Chen L Mol Ther Nucleic Acids. 2024; 35(3):102258.

PMID: 39045516 PMC: 11264179. DOI: 10.1016/j.omtn.2024.102258.


CD3ζ-Mediated Signaling Protects Retinal Ganglion Cells in Glutamate Excitotoxicity of the Retina.

Du R, Wang P, Tian N Cells. 2024; 13(12.

PMID: 38920637 PMC: 11201742. DOI: 10.3390/cells13121006.


CX3CL1-CX3CR1 axis protects retinal ganglion cells by inhibiting microglia activation in a distal optic nerve trauma model.

Yu H, Shen B, Han R, Zhang Y, Xu S, Zhang Y Inflamm Regen. 2024; 44(1):30.

PMID: 38844990 PMC: 11154987. DOI: 10.1186/s41232-024-00343-4.


References
1.
Lindsey J, Duong-Polk K, Hammond D, Chindasub P, Leung C, Weinreb R . Differential protection of injured retinal ganglion cell dendrites by brimonidine. Invest Ophthalmol Vis Sci. 2015; 56(3):1789-804. DOI: 10.1167/iovs.14-13892. View

2.
Schuettauf F, Naskar R, Vorwerk C, Zurakowski D, Dreyer E . Ganglion cell loss after optic nerve crush mediated through AMPA-kainate and NMDA receptors. Invest Ophthalmol Vis Sci. 2000; 41(13):4313-6. View

3.
Briggman K, Helmstaedter M, Denk W . Wiring specificity in the direction-selectivity circuit of the retina. Nature. 2011; 471(7337):183-8. DOI: 10.1038/nature09818. View

4.
Groman-Lupa S, Adewumi J, Park K, Brzezinski Iv J . The Transcription Factor Prdm16 Marks a Single Retinal Ganglion Cell Subtype in the Mouse Retina. Invest Ophthalmol Vis Sci. 2017; 58(12):5421-5433. PMC: 5656415. DOI: 10.1167/iovs.17-22442. View

5.
Feng L, Zhao Y, Yoshida M, Chen H, Yang J, Kim T . Sustained ocular hypertension induces dendritic degeneration of mouse retinal ganglion cells that depends on cell type and location. Invest Ophthalmol Vis Sci. 2013; 54(2):1106-17. PMC: 3567754. DOI: 10.1167/iovs.12-10791. View